ArticleFrontiers in immunology2023

An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial.

Jacob Handlos Grauslund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.